The leadership landscape within the U.S. Department of Health and Human Services (HHS) is undergoing a significant and turbulent transformation,…
Read More
WHO Declares Ebola Outbreak a Public Health Emergency of International Concern Amidst Unprecedented Challenges
The World Health Organization (WHO) has officially declared the current Ebola disease outbreak in Sub-Saharan Africa a public health emergency…
Read More
Tirzepatide Confirmed as Best-in-Class Obesity Therapy Following Landmark SURMOUNT-MAINTAIN Trial Results
Findings from the pivotal Phase III SURMOUNT-MAINTAIN trial, presented at the 33rd European Congress on Obesity (ECO) in Istanbul, Türkiye,…
Read More
Kyowa Kirin Secures FDA Approval for Enhanced Crysvita Dosing Regimen for Adults with X-Linked Hypophosphatemia
Kyowa Kirin has announced a significant advancement in the treatment landscape for X-linked hypophosphatemia (XLH) in adult patients, following the…
Read More
Arna Pharma and Slate Run Pharmaceuticals Forge Strategic Joint Venture to Accelerate Pharmaceutical Product Commercialization in the US Market
Arna Pharma and Slate Run Pharmaceuticals have finalized a significant joint venture (JV), establishing a new specialized pharmaceutical entity poised…
Read More
Tirzepatide Shows Promising Adjunct Benefits in Type 1 Diabetes Management, Meta-Analysis Presented at European Congress on Obesity Suggests
The burgeoning field of GLP-1 receptor agonists, celebrated for their transformative impact on obesity and type 2 diabetes (T2D) management,…
Read More
CGTxchange Launches to Revitalize Shelved Cell and Gene Therapy Programs
The American Society of Gene & Cell Therapy (ASCGT) and Orphan Therapeutics Accelerator (OTXL) have officially unveiled CGTxchange, an innovative,…
Read More
New Study Reveals Oral Semaglutide Outperforms Orforglipron in Weight Loss and Tolerability
Findings presented at the 33rd European Congress on Obesity in Istanbul, Turkey, on May 15th, have provided a crucial comparative…
Read More
Biopharma Leaders Urge Dr. Richard Pazdur to Lead FDA Amidst Crisis of Confidence
The leadership void at the U.S. Food and Drug Administration (FDA) has prompted a significant groundswell of support from the…
Read More
AstraZeneca’s Targeted Treatment Offers New Hope for Stomach Cancer Patients in the UK
AstraZeneca’s groundbreaking targeted therapy, Imfinzi (durvalumab), has secured a pivotal recommendation from the National Institute for Health and Care Excellence…
Read More
